Healcloud's Product Videos
Healcloud's Products & Differentiation
See Healcloud's products and how their products differentiate from alternatives and competitors
Our integrated healthcare data platform, Healinsight Enterprise, enables researchers and administrators to rapidly query and analyze longitudinal health graphs across a network – for any disease – directly extracted from clinical sites’ electronic health records (EHR) systems. The platform generates rich granular data sets, including unstructured data and imaging, while illuminating patient pathways. Our cloud-based software automatically anonymizes the patient data which is already collected in hospitals through their internal data management systems. We organize it, sort it, make it easy and ready to use by researchers in clinical trials to do drug research and identify patients for testing.
When was Healcloud founded?
Healcloud was founded in 2015.
Where is Healcloud's headquarters?
Healcloud's headquarters is located at Anker Business Center, Budapest.
What is Healcloud's latest funding round?
Healcloud's latest funding round is Series A.
How much did Healcloud raise?
Healcloud raised a total of $3.19M.
Who are the investors of Healcloud?
Investors of Healcloud include Hiventures and Hungarian Government.
Who are Healcloud's competitors?
Competitors of Healcloud include TriNetX and 3 more.
What products does Healcloud offer?
Healcloud's products include Healinsight Enterprise.
You May Also Like
Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.
MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.
Oncoshot provides clinical trials and treatment options for cancer patients. Oncoshot allows patients to share their data with trial institutes and sponsors and receive an immediate response, shortening the clinical trial search from weeks to minutes.
COTA brings clarity to cancer care by organizing fragmented, often hidden data from the real world to ensure that everyone touched by cancer has a clear path to the right care. The company combines deep expertise in cancer with proprietary technology and advanced analytics to inform decisions and action. COTA partners with life sciences companies to reveal insights to accelerate drug development; providers, to help uncover previously unknown insights about how care has been delivered to improve quality and outcomes; and payors to help understand how to treat different cancer in a cost-effective way.
PEGASI makes healthcare information accessible, clear and secure for patients and service providers in developing countries, with cost-effective solutions that manage clinical, administrative and financial information smartly, support decision-making using Artificial Intelligence and convert aggregate medical information into Big Data for Public Health vigilance.
Perthera uses AI to analyze patient medical and molecular data to enable hospitals, physicians & advocacy groups to deliver personalized cancer care. The Perthera Platform matches patients to ranked therapeutic options to improve their clinical outcomes and allows patient data access to the key segments in the Precision Oncology market. It was founded in 2012 and is based in McLean, Virginia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.